Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iannis Aifantis

Showing results (81-90 of 206) with videos related to

Pageof 21
Sort By:
Blood Advances|September 22, 2021
Tissue-resident macrophages promote early dissemination of multiple myeloma via IL-6 and TNFαIlseyar Akhmetzyanova, Tonya Aaron, Phillip Galbo, et al.
Blood|February 2, 2006
Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanismsErica J Reschly, Christina Spaulding, Tomas Vilimas, et al.
Science Advances|October 31, 2020
Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow nicheChao Ma, Matthew T Witkowski, Jacob Harris, et al.
The Journal of Experimental Medicine|May 14, 2008
Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7Benjamin J Thompson, Vladimir Jankovic, Jie Gao, et al.
The Journal of Experimental Medicine|March 12, 2025
Leukemogenic Kras mutation reprograms multipotent progenitors to facilitate its spread through the hematopoietic systemGeunhyo Jang, Rosa Park, Eduardo Esteva, et al.
Cell Reports|September 13, 2018
STIM1 and STIM2 Mediate Cancer-Induced Inflammation in T Cell Acute Lymphoblastic LeukemiaShella Saint Fleur-Lominy, Mate Maus, Martin Vaeth, et al.
Nature Immunology|September 27, 2016
The ubiquitin ligase Huwe1 regulates the maintenance and lymphoid commitment of hematopoietic stem cellsBryan King, Francesco Boccalatte, Kelly Moran-Crusio, et al.
Cancer Cell|March 23, 2013
Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progressionLinsey Reavie, Shannon M Buckley, Evangelia Loizou, et al.
Nature Biomedical Engineering|July 2, 2025
Bioengineered immunocompetent preclinical trial-on-chip tool enables screening of CAR T cell therapy for leukaemiaChao Ma, Huishu Wang, Lunan Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2011
T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signalingKristine Germar, Marei Dose, Tassos Konstantinou, et al.
Pageof 21

Showing results (81-90 of 206) with videos related to

Sort By:
Pageof 21
Blood Advances|September 22, 2021
Tissue-resident macrophages promote early dissemination of multiple myeloma via IL-6 and TNFαIlseyar Akhmetzyanova, Tonya Aaron, Phillip Galbo, et al.
Blood|February 2, 2006
Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanismsErica J Reschly, Christina Spaulding, Tomas Vilimas, et al.
Science Advances|October 31, 2020
Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow nicheChao Ma, Matthew T Witkowski, Jacob Harris, et al.
The Journal of Experimental Medicine|May 14, 2008
Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7Benjamin J Thompson, Vladimir Jankovic, Jie Gao, et al.
The Journal of Experimental Medicine|March 12, 2025
Leukemogenic Kras mutation reprograms multipotent progenitors to facilitate its spread through the hematopoietic systemGeunhyo Jang, Rosa Park, Eduardo Esteva, et al.
Cell Reports|September 13, 2018
STIM1 and STIM2 Mediate Cancer-Induced Inflammation in T Cell Acute Lymphoblastic LeukemiaShella Saint Fleur-Lominy, Mate Maus, Martin Vaeth, et al.
Nature Immunology|September 27, 2016
The ubiquitin ligase Huwe1 regulates the maintenance and lymphoid commitment of hematopoietic stem cellsBryan King, Francesco Boccalatte, Kelly Moran-Crusio, et al.
Cancer Cell|March 23, 2013
Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progressionLinsey Reavie, Shannon M Buckley, Evangelia Loizou, et al.
Nature Biomedical Engineering|July 2, 2025
Bioengineered immunocompetent preclinical trial-on-chip tool enables screening of CAR T cell therapy for leukaemiaChao Ma, Huishu Wang, Lunan Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2011
T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signalingKristine Germar, Marei Dose, Tassos Konstantinou, et al.
Pageof 21